Japan Pharma Gearing Up For Battle In Reimbursement Talks As Tax Landscape Shifts
This article was originally published in The Pink Sheet Daily
Executive Summary
Increased consumption tax and tax credits for R&D offer a new playing field as 2014 price revision talks take shape.